Calcium and heart failure: The cycle game - Three new studies examine how a regulator of calcium homeostasis contributes to heart failure in humans and mice

Nature Medicine

Volumn 9, Issue 5, 2003, Pages 508-509

  Chien, Kenneth R ^a   Ross Jr , John ^b   Hoshijima, Masahiko ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOSIN; PHOSPHOLAMBAN; PROTEIN INHIBITOR; RYANODINE RECEPTOR;

CALCIUM HOMEOSTASIS; GENE MUTATION; GENE TRANSFER; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SHORT SURVEY;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; HEART FAILURE, CONGESTIVE; HOMEOSTASIS; HUMANS; MICE; PHOSPHORYLATION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 0038578664     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0503-508     Document Type: Short Survey

References (15)

1. Schmitt, J.P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410-1413 (2003).
2. Haghighi, K. et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111, 869-876 (2003).
3. Song, Q. et al. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J. Clin. Invest. 111, 859-867 (2003).
4. Tada, M. & Toyofuku, T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc. Med. 8, 330-340 (1998).
5. Hasenfuss, G. & Pieske, B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 34, 951-969 (2002).
6. Marx, S.O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365-376 (2000).
7. Minamisawa, S. et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313-322 (1999).
8. Sato, Y. et al. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J. Biol. Chem. 276, 9392-9399 (2001).
9. Freeman, K. et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest. 107, 967-974 (2001).
10. Hoshijima, M. et al. Chronic suppression of heartfailure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8, 864-871 (2002).
11. del Monte, F., Harding, S.E., Dec, G.W., Gwathmey, J.K. & Hajjar, R.I. Targeting phospholamban by gene transfer in human heart failure. Circulation 105, 904-907 (2002).
12. Chien, K.R. Genomic circuits and the integrative biology of cardiac diseases. Nature 407, 227-232 (2000).
13. Towbin, J.A. & Bowles, N.E. The failing heart. Nature 415, 227-233 (2002).
14. 2+ ATPase. Proc. Natl. Acad. Sci. USA 100, 467-472 (2003).
15. Knoll, R. et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111, 943-955 (2002).